Letter by Matthews et al Regarding Article, “Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.